Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162,190,120
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
101,926,921
-
Shares change
-
+4,347,542
-
Total reported value, excl. options
-
$642,596,235
-
Value change
-
+$26,723,556
-
Put/Call ratio
-
136%
-
Number of buys
-
131
-
Number of sells
-
-91
-
Price
-
$6.30
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q2 2025
332 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q2 2025.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101,926,921 shares
of 162,190,120 outstanding shares and own 63% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15,433,212 shares), BlackRock, Inc. (12,743,155 shares), SHAH CAPITAL MANAGEMENT (11,511,780 shares), Sanofi (6,880,481 shares), STATE STREET CORP (6,824,251 shares), D. E. Shaw & Co., Inc. (3,940,960 shares), COATUE MANAGEMENT LLC (3,836,986 shares), GEODE CAPITAL MANAGEMENT, LLC (3,768,353 shares), BANK OF AMERICA CORP /DE/ (3,135,389 shares), and UBS Group AG (2,256,175 shares).
This table shows the top 245 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.